-
Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis.
Hepatology. 1990 Sep;12(3 Pt 1):492-7
PMID: 2401455
-
Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide.
Proc Natl Acad Sci U S A. 1990 Feb;87(4):1620-4
PMID: 2154753
-
Malondialdehyde determination as index of lipid peroxidation.
Methods Enzymol. 1990;186:421-31
PMID: 2233309
-
Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.
Gastroenterology. 1991 Jan;100(1):203-11
PMID: 1983822
-
A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosis.
Gastroenterol Jpn. 1990 Dec;25(6):774-80
PMID: 1980654
-
Hypercholeresis induced by unconjugated bile acid infusion correlates with recovery in bile of unconjugated bile acids.
Hepatology. 1991 Mar;13(3):540-50
PMID: 1999323
-
A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group.
N Engl J Med. 1991 May 30;324(22):1548-54
PMID: 1674105
-
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
Hepatology. 1991 Dec;14(6):1000-7
PMID: 1959845
-
Mechanism of bile acid-induced HCO3-(-)rich hypercholeresis. An analysis based on quantitative acid-base chemistry.
J Hepatol. 1992 Jan;14(1):118-26
PMID: 1737911
-
Immunomodulatory effects of ursodeoxycholic acid on immune responses.
Hepatology. 1992 Aug;16(2):358-64
PMID: 1639344
-
Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide-mediated killing.
FEBS Lett. 1993 Apr 19;321(1):59-62
PMID: 8385630
-
Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes.
Hepatology. 1993 May;17(5):869-81
PMID: 8387948
-
Molecular aspects of membrane stabilization by ursodeoxycholate [see comment].
Gastroenterology. 1993 Jun;104(6):1736-44
PMID: 8388838
-
Hepatoprotective properties of ursodeoxycholic acid.
Gastroenterology. 1993 Jun;104(6):1865-70
PMID: 8500748
-
The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells.
Hepatology. 1993 Jul;18(1):165-72
PMID: 8325607
-
Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium.
J Clin Invest. 1993 Jul;92(1):17-24
PMID: 8325981
-
Measuring free radical reactions in vivo.
Br Med Bull. 1993 Jul;49(3):494-505
PMID: 8221018
-
Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.
Gastroenterology. 1994 Jan;106(1):134-42
PMID: 8276175
-
Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group.
N Engl J Med. 1994 May 12;330(19):1342-7
PMID: 8152446
-
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis.
Gastroenterology. 1994 May;106(5):1284-90
PMID: 8174890
-
Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts.
Gastroenterology. 1994 May;106(5):1333-41
PMID: 8174892
-
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
Hepatology. 1994 May;19(5):1149-56
PMID: 8175136
-
Ursodeoxycholic acid and primary biliary cirrhosis.
BMJ. 1994 Aug 20-27;309(6953):491-2
PMID: 8086896
-
Ursodeoxycholate-induced hypercholeresis in cirrhotic rats: further evidence for cholehepatic shunting.
Hepatology. 1994 Oct;20(4 Pt 1):1048-54
PMID: 7927207
-
Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: dose-response study in isolated rat liver mitochondria.
Hepatology. 1994 Dec;20(6):1595-601
PMID: 7982660
-
Liver cell necrosis: cellular mechanisms and clinical implications.
Gastroenterology. 1995 Jan;108(1):252-75
PMID: 7806049
-
Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis.
J Hepatol. 1994 Oct;21(4):624-33
PMID: 7814810
-
Pharmacology of ursodeoxycholic acid, an enterohepatic drug.
Scand J Gastroenterol Suppl. 1994;204:1-15
PMID: 7824870
-
Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties.
Atherosclerosis. 1994 Nov;111(1):65-78
PMID: 7840815
-
Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection.
J Pharmacol Exp Ther. 1995 Feb;272(2):930-8
PMID: 7853211
-
Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children.
Pharmacol Ther. 1995 Apr;66(1):1-15
PMID: 7630925
-
Protein measurement with the Folin phenol reagent.
J Biol Chem. 1951 Nov;193(1):265-75
PMID: 14907713
-
Biology of disease: free radicals and tissue injury.
Lab Invest. 1982 Nov;47(5):412-26
PMID: 6290784
-
Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?
Lancet. 1987 Apr 11;1(8537):834-6
PMID: 2882236
-
Relationship of bile salt stimulation of colonic epithelial phospholipid turnover and proliferative activity: role of activation of protein kinase C1.
Prev Med. 1987 Jul;16(4):572-9
PMID: 3628203
-
Current concepts: immunology. Monocytes and macrophages.
N Engl J Med. 1988 Mar 24;318(12):747-52
PMID: 3279314
-
Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions.
J Lipid Res. 1989 May;30(5):719-30
PMID: 2760545
-
Bile acid glycine and taurine conjugates in serum of patients with primary biliary cirrhosis: effect of ursodeoxycholic treatment.
Gut. 1989 Aug;30(8):1110-5
PMID: 2767508
-
Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.
Gastroenterology. 1989 Nov;97(5):1268-74
PMID: 2551765
-
Hepatic injury induced by bile salts: correlation between biochemical and morphological events.
Hepatology. 1990 Nov;12(5):1216-21
PMID: 2227821